2025 France Artificial Intelligence (Ai) In Drug Discovery Market Revenue Opportunities Report
Description
The 2025 France Artificial Intelligence (Ai) In Drug Discovery Market Revenue Opportunities Report features 1) market size data for the region or country, 2) annual market growth rates, 3) the market's impact on related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing, 4) Total Addressable Market (TOM) for the four largest market players, 5) Serviceable Addressable Market (SAM), and 6) Serviceable Obtainable Market (SOM)(Wharry Sharpe Research)
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Artificial Intelligence (AI) in Drug Discovery Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the AI-driven drug discovery market in France are Iktos, Owkin, Isomorphic Labs, and Exscientia (with strong collaboration in France). Iktos, based in Paris, leads using generative AI models for de novo drug design and integrates robotics for automated synthesis, accelerating drug development timelines with a focus on inflammatory and autoimmune diseases, oncology, and obesity. Owkin, also headquartered in Paris, leverages AI and machine learning to integrate biological data for precision medicine, especially in oncology, and has major partnerships with Sanofi and Bristol-Myers Squibb. Isomorphic Labs, a Google DeepMind sister company, applies cutting-edge AI for drug design and protein structure prediction, collaborating with Novartis and Eli Lilly in France. Exscientia, though UK-based, has significant collaborations in France and globally, focusing on AI-driven precision drug design and recently expanding partnerships with pharma giants like Merck. These firms embody France’s prominence in the AI drug discovery landscape through innovation in generative models, biological data integration, and strategic pharma collaborations.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Artificial Intelligence (AI) in Drug Discovery Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the AI-driven drug discovery market in France are Iktos, Owkin, Isomorphic Labs, and Exscientia (with strong collaboration in France). Iktos, based in Paris, leads using generative AI models for de novo drug design and integrates robotics for automated synthesis, accelerating drug development timelines with a focus on inflammatory and autoimmune diseases, oncology, and obesity. Owkin, also headquartered in Paris, leverages AI and machine learning to integrate biological data for precision medicine, especially in oncology, and has major partnerships with Sanofi and Bristol-Myers Squibb. Isomorphic Labs, a Google DeepMind sister company, applies cutting-edge AI for drug design and protein structure prediction, collaborating with Novartis and Eli Lilly in France. Exscientia, though UK-based, has significant collaborations in France and globally, focusing on AI-driven precision drug design and recently expanding partnerships with pharma giants like Merck. These firms embody France’s prominence in the AI drug discovery landscape through innovation in generative models, biological data integration, and strategic pharma collaborations.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
Table of Contents
51 Pages
- A. Definitions
- A1. Market Definition
- A2. Market Segmentation
- A3. Industry Opportunities-Industry1
- A4. Industry Opportunities-Industry2
- A5. Industry Opportunities-Industry3
- B. Total Addressable Market (TAM)
- B1. TAM-Player 1/4
- B2. TAM-Player 2/4
- B3. TAM-Player 3/4
- B4. TAM-Player 4/4
- C. Serviceable Addressable Market (SAM)
- C1. SAM-Player 1/4
- C2. SAM-Player 2/4
- C3. SAM-Player 3/4
- C4. SAM-Player 4/4
- D. Serviceable Obtainable Market (SOM)
- D1. SOM-Player 1/4
- D2. SOM-Player 2/4
- D3. SOM-Player 3/4
- D4. SOM-Player 4/4
- E. Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
